Vaccination of travelers: how far have we come and where are we going?. (November 2011)

• Record Type: Journal Article
• Authors: Chen, Lin H; Hill, David R; Wilder-Smith, Annelies
• Is Part Of: Expert review of vaccines. Volume 10:Number 11(2011)
• Page Start: 1609
• Page End: 1620
• Publication Date: 2011-11
• Subjects: cholera vaccine -- dengue vaccine -- hepatitis A and B -- influenza vaccine -- Japanese encephalitis -- malaria vaccine -- meningococcal vaccine -- rabies vaccine -- tick-borne encephalitis vaccine -- travel vaccines -- yellow fever vaccine; Vaccines -- Periodicals; Vaccination -- Periodicals; 615.37205
• DOI: 10.1586/erv.11.138
• Languages: English
• ISSNs: 1476-0584

Abstract

Vaccine recommendations are a prominent part of health preparations before international travel. We review progress made in the past decade regarding vaccines used primarily by persons traveling from high-income countries to low- and middle-income countries. The combined hepatitis A–B vaccine, the recently licensed Vero cell-derived Japanese encephalitis vaccine and conjugated quadrivalent meningococcal vaccines are discussed. This article provides updates on yellow fever vaccine-associated visceral and neurologic adverse events, indications for influenza vaccine in travelers, the rapid immunization schedule for tick-borne encephalitis vaccine, schedules for postexposure rabies prophylaxis, and new insights about oral cholera vaccines following the outbreak in Haiti. The future should bring vaccines for serogroup B Neiserria meningitidis, dengue and malaria, as well as an inactivated yellow fever vaccine.